{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:48:12Z","timestamp":1791118092364,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.urolonc.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T07:33:32Z","timestamp":1306481612000},"page":"576-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison"],"prefix":"10.1016","volume":"31","author":[{"given":"Ahmed","family":"Eldefrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendar","family":"Katkoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Soloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugesan","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2011.04.005_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2011.04.005_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.urolonc.2008.03.003","article-title":"What is the best approach for screen-detected low volume cancers?\u2014The case for observation","volume":"26","author":"Klotz","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.urology.2005.06.116","article-title":"Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function (\u201ctrifecta\u201d)","volume":"66","author":"Bianco","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2011.04.005_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1464-410x.2001.00115.x","article-title":"Robotically-assisted laparoscopic radical prostatectomy","volume":"87","author":"Binder","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.04.005_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00464-010-1210-z","article-title":"Assessing the complications of laparoscopic robot-assisted surgery: The case of radical prostatectomy","volume":"25","author":"Lebeau","year":"2011","journal-title":"Surg Endosc"},{"key":"10.1016\/j.urolonc.2011.04.005_bib6","article-title":"Robot-assisted extraperitoneal laparoscopic radical prostatectomy: A review of the current literature","author":"Xylinas","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib7","first-page":"193","article-title":"The current state of robot assisted radical prostatectomy","volume":"62","author":"Khatlani","year":"2010","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijrobp.2007.12.041","article-title":"Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity results","volume":"72","author":"Lim","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2011.04.005_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00345-009-0418-9","article-title":"Radical retropubic prostatectomy vs. brachytherapy for low-risk prostatic cancer: A prospective study","volume":"27","author":"Giberti","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2008.07553.x","article-title":"Active surveillance: A safe, low-cost prognostic test for prostate cancer","volume":"101","author":"Zietman","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.04.005_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2010.08.027","article-title":"Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment","volume":"58","author":"Soloway","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib12","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.juro.2008.11.109","article-title":"A multi-institutional evaluation of active surveillance for low risk prostate cancer","volume":"181","author":"Eggener","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib13","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2010.1720","article-title":"Active surveillance compared with initial treatment for men with low-risk prostate cancer: A decision analysis","volume":"304","author":"Hayes","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2011.04.005_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/clpt.2010.179","article-title":"Where cost, medical necessity, and morality meet: Should US government insurance programs pay for erectile dysfunction drugs?","volume":"89","author":"Polinski","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.urolonc.2011.04.005_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1464-410X.2009.08532.x","article-title":"Robotic vs. open prostatectomy in a laparoscopically naive center: A matched-pair analysis","volume":"104","author":"Rocco","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2011.04.005_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-142-10-200505170-00010","article-title":"High and rising health care costs","volume":"142","author":"Bodenheimer","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2011.04.005_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-142-11-200506070-00012","article-title":"High and rising health care costs","volume":"142","author":"Bodenheimer","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2011.04.005_bib18","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.juro.2007.01.121","article-title":"Prostate cancer","volume":"177","author":"Penson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib19","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/01.ju.0000181830.43340.e7","article-title":"Local cost structures and the economics of robot assisted radical prostatectomy","volume":"174","author":"Scales","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib20","first-page":"35","article-title":"Open vs. laparoscopic vs. robot-assisted laparoscopic prostatectomy: The European and US Experience","volume":"12","author":"Finkelstein","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JOP.091074","article-title":"Impact of the cost of cancer treatment: An internet-based survey","volume":"6","author":"Markman","year":"2010","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.urolonc.2011.04.005_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.canrad.2010.06.013","article-title":"Benefit of intensity modulated and image-guided radiotherapy in prostate cancer","volume":"14","author":"Latorzeff","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.urolonc.2011.04.005_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOU.0b013e328329eb00","article-title":"Quality of life outcomes following treatment for localized prostate cancer: Is there a clear winner?","volume":"19","author":"Parker","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","article-title":"Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial","volume":"64","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2011.04.005_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2011.04.005_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.urolonc.2009.02.003","article-title":"The second decade of prostate brachytherapy: Evidence and cost based outcomes","volume":"28","author":"Vigneri","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2011.04.005_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00365590902834802","article-title":"Open retropubic prostatectomy vs. robot-assisted laparoscopic prostatectomy: A comparison of length of sick leave","volume":"43","author":"Hohwu","year":"2009","journal-title":"Scand J Urol Nephrol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143911001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:00:15Z","timestamp":1761040815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143911001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1078143911001347"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.04.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2011.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}